Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Kaitlin Batley

Neurology with Special Qualifications in Child Neurology Dallas, TX Medical Doctor

NPI 1124412028 CMS profile 9838894

1935 Medical District Dr, Dallas, TX 75235

Open in the dashboard

General payments

$73,645

176 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$466,033 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Kaitlin Batley of Dallas, TX is reported in the CMS Open Payments database as having received $73,645 across 176 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $466,033 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,116 65
2024 General $25,067 42
2023 General $7,606 52
2022 General $7,856 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kaitlin Batley
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Kaitlin Batley were reported at $33,116. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Kaitlin Batley Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $0 $262 $68–$1,313 $163
2020 $0 $188 $46–$1,222 $114
2021 $0 $183 $45–$1,356 $132
2022 $7,856 $229 $72–$1,177 $149
2023 $7,606 $269 $93–$1,195 $160
2024 $25,067 $300 $98–$1,428 $164
2025 $33,116 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Sarepta Therapeutics, Inc. $17,940 29 payments
  2. Novartis Pharmaceuticals Corporation $11,629 10 payments
  3. Pfizer Inc. $8,668 8 payments
  4. Biogen, Inc. $8,428 18 payments
  5. ITF Therapeutics LLC $5,828 19 payments
  6. PTC Therapeutics, Inc. $5,707 6 payments
  7. Janssen Scientific Affairs, LLC $5,015 10 payments
  8. Catalyst Pharmaceuticals, Inc. $4,405 7 payments
  9. UCB, Inc. $3,580 13 payments
  10. Genentech, Inc. $769 4 payments
  11. Other $1,676 52 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Consulting Fee $43,995 14 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,509 4 payments
  3. Travel and Lodging $7,558 26 payments
  4. Food and Beverage $6,706 128 payments
  5. Honoraria $3,848 3 payments
  6. Education $30 1 payment
Products named General payments · program years 2022–2025
  1. Elevidys $16,976 20 payments
  2. EMFLAZA $5,681 5 payments
  3. ZOLGENSMA $5,369 5 payments
  4. AGAMREE $4,383 6 payments
  5. SPINRAZA $4,069 11 payments
  6. Evrysdi $1,287 21 payments
  7. VILTEPSO $236 14 payments
  8. VYVGART $168 2 payments
  9. Rystiggo $123 2 payments
  10. Epidiolex $71 2 payments
  11. Other $477 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record